Growth Metrics

Eledon Pharmaceuticals (ELDN) EBIT Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 12.69%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 75.16%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -347.04%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 80.62%
7 Evaxion A 62.56 Bn 62.54 Bn - 1.27%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.65%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1,386.07%
10 Eledon Pharmaceuticals 419.90 Mn 203.87 Mn - -17.91%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -17.91%
Sep 30, 2025 7.02%
Jun 30, 2025 -70.55%
Mar 31, 2025 -65.28%
Dec 31, 2024 368.59%
Sep 30, 2024 -83.16%
Jun 30, 2024 -40.06%
Mar 31, 2024 2.17%
Dec 31, 2023 -27.32%
Sep 30, 2023 -5.66%
Jun 30, 2023 -11.54%
Mar 31, 2023 -12.69%
Dec 31, 2022 -42.93%
Sep 30, 2022 -0.88%
Jun 30, 2022 -16.46%
Mar 31, 2022 -9.48%
Dec 31, 2021 410.98%
Sep 30, 2021 -70.88%
Jun 30, 2021 -207.64%
Mar 31, 2021 -166.58%
Dec 31, 2020 -52.34%
Sep 30, 2020 -110.55%
Jun 30, 2020 36.63%
Mar 31, 2020 30.71%
Dec 31, 2019 8.96%
Sep 30, 2019 16.55%
Jun 30, 2019 -28.22%
Mar 31, 2019 -74.42%
Dec 31, 2018 -117.43%
Sep 30, 2018 -18.01%
Jun 30, 2018 52.16%
Mar 31, 2018 -101.81%
Dec 31, 2017 44.02%
Sep 30, 2017 -83.36%
Jun 30, 2017 -615.24%
Mar 31, 2017 87.94%
Dec 31, 2016 66.04%
Sep 30, 2016 86.42%
Jun 30, 2016 89.62%
Mar 31, 2016 13.68%
Dec 31, 2015 -76.84%
Sep 30, 2015 -85.35%
Jun 30, 2015 -52.63%
Mar 31, 2015 -171.87%
Dec 31, 2014 -12.83%
Sep 30, 2014 -90.91%